U.S. Markets closed

Zogenix, Inc. (ZGNX)


NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
14.30-0.45 (-3.05%)
At close: 4:00PM EDT

14.30 0.00 (0.00%)
After hours: 4:59PM EDT

People also watch
GALESNTAACRXSGYPAVEO

Zogenix, Inc.

5858 Horton Street
Suite 455
Emeryville, CA 94608
United States
510-550-8300
http://www.zogenix.com

SectorHealthcare
IndustryDrug Manufacturers - Major
Full Time Employees67

Key Executives

NameTitlePayExercisedAge
Dr. Stephen J. Farr Ph.D.Co-Founder, Chief Exec. Officer, Pres and Director677.89kN/A58
Mr. Roger L. HawleyCo-Founder and DirectorN/AN/A64
Dr. Bradley S. Galer M.D.Chief Medical Officer and Exec. VP510.23kN/A55
Dr. Gail M. Farfel Ph.D.Chief Devel. Officer and Exec. VP477.06kN/A53
Dr. Thierry J. P. Darcis M.D.Exec. VP and Gen. Mang. of Europe - Zogenix International Limited447.47kN/A54
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders in the United States. The company’s lead product candidate is the ZX008, a low-dose fenfluramine, which is in Phase III clinical trials for the treatment of seizures associated with Dravet syndrome. It also develops Relday, an injectable formulation of risperidone to treat the symptoms of schizophrenia and bipolar disorder in adults and teenagers with 13 years of age and older. The company was formerly known as SJ2 Therapeutics, Inc. and changed its name to Zogenix, Inc. in August 2006. Zogenix, Inc. was founded in 2006 and is headquartered in Emeryville, California.

Corporate Governance

Zogenix, Inc.’s ISS Governance QualityScore as of June 2, 2017 is 9. The pillar scores are Audit: 5; Board: 3; Shareholder Rights: 8; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.